# 1. SAFETY AND EFFECTIVENESS AS REQUIRED BY 21 CFR 807.92 STATEMENT

This summary of the 510(k) safety and effectiveness information is being submitted in accordance with the requirement 21 CFR 807.92.

2. SUBMITTER NAME AND ADDRESS

Name: Randox Laboratories Limited

Address: 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom.

Telephone: +44 (0) 28 9442 2413 Fax: +44 (0) 28 9445 2912 E-mail: marketing@randox.com

# 3. 510k NUMBER, DEVICE PROPRIETARY NAME, COMMON NAME, PURPOSE FOR SUBMISSION, REGULATORY CLASSIFCATION, PANEL, PRODUCT CODE AND 21 CFR NUMBER

510k No: k122126

Device Proprietary Name: Randox Direct LDL/HDL Cholesterol Calibrator

Common Name: Direct LDL/HDL Cholesterol Calibrator

Purpose for Submission: New Device

Regulatory Classification: Primary Calibrator Class II

Panel: Clinical Chemistry

Product Code: JIS

21 CFR Number: 21 CFR 862.1150

# 4. PREDICATE DEVICE PROPRIETARY NAME AND 510 (k) NUMBER

Predicate Device Proprietary Name: Teco Diagnostics Direct HDL/LDL Cholesterol Calibrator

510 (k) Number: k050823

# 5. INTENDED USE

The Randox Direct LDL/HDL Cholesterol Calibrator is intended for in vitro diagnostic use in the calibration of Randox HDL and LDL cholesterol methods. This in vitro diagnostic device is intended for prescription use only and can only be used by professionals.

# 6. DEVICE DESCRIPTION

The Randox Direct LDL/HDL Cholesterol Calibrator is supplied in a kit containing 3x1mls vials. The calibrator contains the analytes LDL and HDL.

The base matrix used for the manufacture of Randox Direct LDL/HDL Cholesterol Calibrator is Human Serum. The calibrator contains lipoproteins from the various lipoprotein classes including high density lipoproteins.

<table><tr><td rowspan=1 colspan=1>CHARACTERISTICS</td><td rowspan=1 colspan=1>RANDOX DIRECT LDL/HDLCHOLESTEROL CALIBRATOR</td><td rowspan=1 colspan=1>TECO DIAGNOSTICS DIRECTHDL/LDL CHOLESTEROLCALIBRATOR</td></tr><tr><td rowspan=1 colspan=1>INTENDED USE</td><td rowspan=1 colspan=1>The Randox Direct LDL/HDL CholesterolCalibrator is intended for in vitrodiagnostic use in the calibration ofRandox HDL and LDL Cholesterolmethods.This in vitro diagnostic device is intendedfor prescription use only and can only beused by professionals.</td><td rowspan=1 colspan=1>The Teco Diagnostics Direct HDL/LDLCholesterol Calibrator is intended for thecalibration of Teco Diagnostics&#x27; directHDL and LDL Cholesterol Reagent set inserum or plasma.For in vitro diagnostic use only.</td></tr><tr><td rowspan=1 colspan=1>SIZE</td><td rowspan=1 colspan=1>Randox Direct LDL/HDL Cholesterolcalibrator 3x1ml</td><td rowspan=1 colspan=1>Teco Diagnostics Direct HDL/LDLCholesterol Calibrator 3mls</td></tr><tr><td rowspan=1 colspan=1>FORMAT</td><td rowspan=1 colspan=1>Lyophilized serum calibrator</td><td rowspan=1 colspan=1>Lyophilized serum calibrator</td></tr><tr><td rowspan=1 colspan=1>MATRIX</td><td rowspan=1 colspan=1>Human Serum. The calibrator containslipoproteins from the various lipoproteinclasses including high density lipoproteins</td><td rowspan=1 colspan=1>Human Serum. The calibrator containslipoproteins from the various lipoproteinclasses including high density lipoproteins</td></tr><tr><td rowspan=1 colspan=1>STORAGE(unopened)</td><td rowspan=1 colspan=1>Stable to the expiry date printed on theproduct label when stored between +2and +8</td><td rowspan=1 colspan=1>Stable to the expiry date printed onthe product label when storedbetween +2C and +8</td></tr><tr><td rowspan=1 colspan=1>STORAGE(Opened)</td><td rowspan=1 colspan=1>Once reconstituted, the components inthe calibrator are stable for 5 days at+2C to +8</td><td rowspan=1 colspan=1>Once reconstituted, the components inthe calibrator are stable for 21 days at+2C to +8</td></tr><tr><td rowspan=1 colspan=1>ANALYTES</td><td rowspan=1 colspan=1>Direct LDLDirect HDL</td><td rowspan=1 colspan=1>Direct LDLDirect HDL</td></tr></table>

# 8. SUMMARY OF STABILITY STUDIES

Unopened Calibrator is stable until the expiry date printed on the product label when stored between $\yen 20$ and $+ 8 ^ { \circ } C$ Once reconstituted the components are stable for 5 days at $\yen 20$ and $+ 8 ^ { \circ } C$ and 1 month at $\tt - 2 0 \%$ when frozen once. After use, any residual product should NOT be returned to the original vial.

# 9. SUMMARY OF VALUE ASSIGNMENT

The assigned values for the direct LDL/HDL Cholesterol Calibrator are established on multiple analysers with reference to a master lot.

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>System</td><td rowspan=1 colspan=2>Target</td></tr><tr><td rowspan=1 colspan=1>Y</td><td rowspan=1 colspan=1>Y</td><td rowspan=1 colspan=1>mmol/l</td><td rowspan=1 colspan=1>mg/dl</td></tr><tr><td rowspan=7 colspan=1>Direct HDL</td><td rowspan=1 colspan=1>Abbott Architect c8000</td><td rowspan=1 colspan=1>1.77</td><td rowspan=1 colspan=1>68.3</td></tr><tr><td rowspan=1 colspan=1>Beckman Coulter AU640</td><td rowspan=1 colspan=1>1.73</td><td rowspan=1 colspan=1>66.8</td></tr><tr><td rowspan=1 colspan=1>Hitachi 717</td><td rowspan=1 colspan=1>1.67</td><td rowspan=1 colspan=1>64.5</td></tr><tr><td rowspan=1 colspan=1>Hitachi 911</td><td rowspan=1 colspan=1>1.65</td><td rowspan=1 colspan=1>63.7</td></tr><tr><td rowspan=1 colspan=1>Randox RX Daytona</td><td rowspan=1 colspan=1>1.73</td><td rowspan=1 colspan=1>66.8</td></tr><tr><td rowspan=1 colspan=1>Randox Rx Imola</td><td rowspan=1 colspan=1>1.65</td><td rowspan=1 colspan=1>63.7</td></tr><tr><td rowspan=1 colspan=1>Siemens Advia 1650</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>65.6</td></tr><tr><td rowspan=6 colspan=1>Direct LDL</td><td rowspan=1 colspan=1>Beckman Coulter AU640</td><td rowspan=1 colspan=1>3.16</td><td rowspan=1 colspan=1>122</td></tr><tr><td rowspan=1 colspan=1>Hitachi 717</td><td rowspan=1 colspan=1>3.01</td><td rowspan=1 colspan=1>116</td></tr><tr><td rowspan=1 colspan=1>Hitachi 911</td><td rowspan=1 colspan=1>3.03</td><td rowspan=1 colspan=1>117</td></tr><tr><td rowspan=1 colspan=1>Randox RX Daytona</td><td rowspan=1 colspan=1>3.11</td><td rowspan=1 colspan=1>120</td></tr><tr><td rowspan=1 colspan=1>Randox Rx Imola</td><td rowspan=1 colspan=1>3.12</td><td rowspan=1 colspan=1>120</td></tr><tr><td rowspan=1 colspan=1>Siemens Advia 1650</td><td rowspan=1 colspan=1>3.09</td><td rowspan=1 colspan=1>119</td></tr></table>

# 10. TRACEABILITY

<table><tr><td rowspan=1 colspan=1>ANALYTE</td><td rowspan=1 colspan=1>SUPPLIER</td><td rowspan=1 colspan=1>PRODUCTNUMBER</td><td rowspan=1 colspan=1>ORIGIN</td><td rowspan=1 colspan=1>SOURCE</td></tr><tr><td rowspan=1 colspan=1>Direct HDL</td><td rowspan=1 colspan=1>Creative Labs</td><td rowspan=1 colspan=1>361-10</td><td rowspan=1 colspan=1>Human</td><td rowspan=1 colspan=1>Plasma</td></tr><tr><td rowspan=1 colspan=1>Direct LDL</td><td rowspan=1 colspan=1>Creative Labs</td><td rowspan=1 colspan=1>360-10</td><td rowspan=1 colspan=1>Human</td><td rowspan=1 colspan=1>Plasma</td></tr></table>

# 11. CONCLUSION

Testing results indicate that the proposed device is substantially equivalent to the predicate device

Randox Laboratories Ltd.   
c/o Pauline Armstrong   
55 Diamond Road   
Crumlin, County Antrim BT29 4QY United Kingdom

Re: k122126 Trade Name: Randox Direct LDL/HDL Cholesterol Calibrator Regulation Number: 21 CFR ยง862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Codes: JIS Dated: July 18, 2012 Received: July 18, 2012

Dear Ms. Armstrong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed i interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the gereral controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2

Couptney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): k122126

Device Name: Direct LDL/HDL Cholesterol Calibrator

Indication for Use:

The Randox Direct LDL/HDL Cholesterol Calibrator is intended for in vitro diagnostic use in the calibration of Randox HDL and LDL Cholesterol methods.

This in vitro diagnostic device is intended for prescription use only and can only be used by professionals.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/26aaf9f227eaba61ce737b75d0cb3d4a29608025e10e6bb56c81f9b5d5b83067.jpg)

Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety